Organic allergen balm specialist HayMax has been recognised at this year’s M&A Today Global Awards, winning in the category of Leading Pharmaceutical Company. These awards “celebrate unparalleled excellence globally”, with participation from over 163 countries.

HayMax’s achievement in the M&A Today Awards signifies the company’s ‘dedication and strategic innovation in the industry’, setting it apart as a global leader. 

Commenting on the Award, HayMax MD Max Wiseberg, said: “We are delighted to receive this global award as recognition of our innovative product and expansion into overseas markets from our traditional UK base. This is a great achievement for a small company to win on a global scale.”

HayMax takes a different approach to most hay fever treatments and remedies. It works on the prevention principle by seeking to stop pollen getting into the body before it can cause a reaction, rather than attempting to treat the symptoms or the effects of the pollen once they occur.

A pioneer in the sector for two decades, HayMax has now won over 60 awards, including for 2023 a Soil Association BOOM Award, British Made Award, Enterprise Award, BizzieBaby Award, Global 100 Award and Corporate America Today Annual Award.